NEUROSCIENCE OF HIV

描述(改编自申请人的摘要)：本申请寻求 支持第八届国际艾滋病毒神经科学大会 “感染：基础和临床前沿1998”将在芝加哥举行， 伊利诺伊州，1998年6月3日至6日。这次会议的目标是，以前是一个 卫星研讨会将为国际艾滋病大会带来 聚集了世界上病理生理机制和 神经学、神经心理学和神经病学的临床表现 人类免疫缺陷病毒(HIV)感染的精神并发症。 这次会议是一种传播有关 广泛性HIV相关疾病的发病机制和表现 神经系统。这次关于神经科学的国际会议 HIV是在1988年构思和开发的，当时联合创始人(Dr.J.Berger) 和R.Levy)认识到神经科学家在 艾滋病问题国际会议，介绍和讨论 与艾滋病毒对神经系统的影响有关的工作。第一届年度 第五次国际会议之前在魁北克市举行的会议 蒙特利尔艾滋病大会有来自世界各地的220多名参与者。 会议的后续地点包括加利福尼亚州的蒙特利 (1990年)、帕多瓦(1991年)、阿姆斯特丹(1992年)、维也纳(1993年)、温哥华(1994年) 《巴黎》(1996)。出席会议的人数从150人到275人不等。 在世界各地有代表权的人。这次会议一直是一个 鼓励该学科的年轻调查人员的机制。格式 因为这次会议是由国际上的全体会议组成的 公认的与科学有关的权威机构(平台和 海报)演示。随着会议的成熟，法律和 一个由国际专家组成的咨询委员会，广泛代表 已经为这次会议建立了艾滋病毒的神经科学。

DESCRIPTION (Adapted from the Applicant's Abstract): This application seeks support for the conference, "The Eighth International Neuroscience of HIV Infection: Basic and Clinical Frontiers 1998" to be held in Chicago, Illinois, June 3rd-6th, 1998. The goal of this conference, formerly a satellite symposium to the International Conference on AIDS, is to bring together the world's experts in the pathophysiological mechanisms and clinical manifestations of the neurological, neuropsychological, and psychiatric complications of human immunodeficiency virus (HIV) infection. The conference serves as a means to disseminate new information on the pathogeneses and manifestations of the broad range HIV-related disorders of the nervous system. This international conference on the neuroscience of HIV was conceived and developed in 1988 when the co-founders (Drs.J. Berger and R. Levy) recognized the limited forum available to neuroscientists at the International Conference on AIDS, for the presentation and discussion of works related to the effects of HIV on the nervous system. The first annual meeting held in Quebec City, prior to the 5th International Conference on AIDS in Montreal, had over 220 participants from around the world. Subsequent sites of the conference have included Monterey, California (1990), Padua (1991), Amsterdam (1992), Vienna (1993), Vancouver (1994), and Paris (1996). Attendance at the conference has varied from 150 to 275 persons, with worldwide representation. The conference has served as a mechanism to encourage young investigators in the discipline. The format for the conference is a combination of plenary sessions by internationally recognized authorities in association with scientific (both platform and poster) presentations. With the maturation of the conference, by laws and an advisory board of international experts, broadly representative of the neuroscience of HIV, have been established for the conference.